4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine has been researched along with atomoxetine in 1 studies
| Studies (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Trials (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Recent Studies (post-2010) (4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine) | Studies (atomoxetine) | Trials (atomoxetine) | Recent Studies (post-2010) (atomoxetine) |
|---|---|---|---|---|---|
| 42 | 0 | 9 | 41 | 0 | 11 |
| Protein | Taxonomy | 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine (IC50) | atomoxetine (IC50) |
|---|---|---|---|
| Cytochrome P450 2D6 | Homo sapiens (human) | 2 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 3 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.0042 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 2 | |
| Type-1 angiotensin II receptor | Bos taurus (cattle) | 0.18 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.1434 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 3.0429 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 2.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
1 other study(ies) available for 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine and atomoxetine
| Article | Year |
|---|---|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |